A single-centre, open-label, randomized controlled trial of efficacy, safety and usability of a basal insulin algorithm incorporated in the GlucoTab system compared to standard care for glycaemic management in geriatric patients with type 2 diabetes at acute geriatric care wards
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Feb 2019 Status changed from recruiting to completed.
- 16 Jul 2018 Status changed from not yet recruiting to recruiting.
- 19 May 2017 New trial record